Literature DB >> 2059221

Molecular cloning of an adducin-like protein: evidence of a polymorphism in the normotensive and hypertensive rats of the Milan strain.

G Tripodi1, A Piscone, G Borsani, S Tisminetzky, S Salardi, A Sidoli, P James, S Pongor, G Bianchi, F E Baralle.   

Abstract

Differences genetically associated with the development of hypertension in a strain of genetically hypertensive rat (MHS) were described in ion transport across erythrocyte membranes compared to normotensive control (MNS). Antibodies against the MNS ghost proteins were raised in the MHS, producing an immunoreaction against a 105 KDa protein later identified as adducin. A clone coding for a portion of mouse adducin was isolated with these antibodies. Using this clone, overlapping cDNA clones coding for a 63 KDa adducin-like protein were isolated. A family of related mRNAs of about 3500, 3800, 4200 nt, was found to be present in spleen, kidney and heart tissues. Similar mRNAs and an additional tissue specific 8000 nt mRNA are present in brain. All mRNAs seem to be generated by alternative splicing from the transcript of a single gene. An interesting polymorphism, a Gln to Arg substitution, was detected in the carboxiterminal area of rat adducin 63.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 2059221     DOI: 10.1016/0006-291x(91)90629-l

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  13 in total

1.  New nucleotide sequence data on the EMBL File Server.

Authors: 
Journal:  Nucleic Acids Res       Date:  1992-01-11       Impact factor: 16.971

Review 2.  Personalized Therapy of Hypertension: the Past and the Future.

Authors:  Paolo Manunta; Mara Ferrandi; Daniele Cusi; Patrizia Ferrari; Jan Staessen; Giuseppe Bianchi
Journal:  Curr Hypertens Rep       Date:  2016-03       Impact factor: 5.369

3.  Identification of a region of rat chromosome 1 that impairs the myogenic response and autoregulation of cerebral blood flow in fawn-hooded hypertensive rats.

Authors:  Mallikarjuna R Pabbidi; Julio Juncos; Luis Juncos; Marija Renic; Hurtis J Tullos; Jozeph Lazar; Howard J Jacob; David R Harder; Richard J Roman
Journal:  Am J Physiol Heart Circ Physiol       Date:  2012-11-09       Impact factor: 4.733

4.  TDP-43 regulates β-adducin (Add2) transcript stability.

Authors:  Luisa Costessi; Fabiola Porro; Alessandra Iaconcig; Andrés F Muro
Journal:  RNA Biol       Date:  2014       Impact factor: 4.652

Review 5.  The adducin saga: pleiotropic genomic targets for precision medicine in human hypertension-vascular, renal, and cognitive diseases.

Authors:  Ezekiel Gonzalez-Fernandez; Letao Fan; Shaoxun Wang; Yedan Liu; Wenjun Gao; Kirby N Thomas; Fan Fan; Richard J Roman
Journal:  Physiol Genomics       Date:  2021-12-03       Impact factor: 3.107

6.  Two point mutations within the adducin genes are involved in blood pressure variation.

Authors:  G Bianchi; G Tripodi; G Casari; S Salardi; B R Barber; R Garcia; P Leoni; L Torielli; D Cusi; M Ferrandi
Journal:  Proc Natl Acad Sci U S A       Date:  1994-04-26       Impact factor: 11.205

7.  Calmodulin-binding domain of recombinant erythrocyte beta-adducin.

Authors:  D A Scaramuzzino; J S Morrow
Journal:  Proc Natl Acad Sci U S A       Date:  1993-04-15       Impact factor: 11.205

Review 8.  Genetics of Human Primary Hypertension: Focus on Hormonal Mechanisms.

Authors:  Worapaka Manosroi; Gordon H Williams
Journal:  Endocr Rev       Date:  2019-06-01       Impact factor: 19.871

9.  Upregulation of the Renin-Angiotensin-aldosterone-ouabain system in the brain is the core mechanism in the genesis of all types of hypertension.

Authors:  Hakuo Takahashi
Journal:  Int J Hypertens       Date:  2012-12-17       Impact factor: 2.420

10.  Characterization of the distal polyadenylation site of the ß-adducin (Add2) pre-mRNA.

Authors:  Luisa Costessi; Fabiola Porro; Alessandra Iaconcig; Mirjana Nedeljkovic; Andrés Fernando Muro
Journal:  PLoS One       Date:  2013-03-15       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.